Prevention of mother-to-child transmission

Prevention of mother-to-child transmission features

• 

  South Africa is moving towards an AIDS-free generation, and improving survival in children living with HIV

  Reductions in vertical HIV transmission to infants and improvement in paediatric survival attributable to the scale of and quality improvement of prevention of parent-to-child transmission (PPTCT) and antiretroviral...

  From:HIV & AIDS treatment in practice

• 

  Happy families

  Sally Farthing is an HIV specialist midwife at West Middlesex Hospital in Isleworth, west London. She praises the measures – and the mothers – who together have sent...

  From:HIV treatment update

• 

  Audit of high infant mortality in Durban hospitals illustrates delivery gap remaining for PMTCT and paediatric ART programmes

  Review of ways in which perinatal and child care may currently fail to identify HIV-infected infants, and what needs to be done to improve linkage...

  From:HIV & AIDS treatment in practice

• 

  HIV treatment for mothers and children in Botswana: lessons from a dynamic programme

  Lessons from the Botswana national PMTCT programme on scaling up antiretroviral treatment for mothers and children....

  From:HIV & AIDS treatment in practice

• 

  Safer infant feeding update, part 2

  Debates over early weaning, community support for mothers with HIV and ways of improving the nutritional quality of alternatives to breastfeeding....

  From:HIV & AIDS treatment in practice

• 

  Safer infant feeding update

  Review of 2006 evidence on the risks of replacement feeding in infants of HIV-positive mothers....

  From:HIV & AIDS treatment in practice

• 

  Getting the most prevention and care out of programmes for the prevention of mother-to-child transmission

  Review of evidence from the 2006 HIV Implementers' meeting on how PMTCT programmes can be intergrated into, and strengthen, maternal-child health services....

  From:HIV & AIDS treatment in practice

• 

  HATIP #57, 28th October, 2005

  ...

  From:HIV & AIDS treatment in practice

• 

  Revised 2005 WHO guidelines on prevention of mother-to-child transmission

  Earlier this month, the World Health Organization issued proposed revisions to its recommendations on the use of antiretroviral drugs for the prevention of mother-to-child transmission...

  From:HIV & AIDS treatment in practice

• 

  Safer infant feeding

  Review of evidence about infant feeding choices and operational issues around promotion of exclusive breatsfeeding by mothers with HIV....

  From:HIV & AIDS treatment in practice

Prevention of mother-to-child transmission in your own words

• 

  Becoming an assertive woman

  I was born in 1977, during the apartheid regime. This situation forced my parents to cross the border for the liberation struggle, when I was four months...

  From:In your own words

• 

  Live on, live long

  Twenty-one years on… I have been living with HIV for 21 years and I am now on second-line treatment. When I am doing counselling with people who...

  From:In your own words

• 

  Preventing mother-to-child transmission

  I found out about my HIV status when I was 16 weeks pregnant. After I had an HIV test, I had counselling with the midwife....

  From:In your own words

• 

  Bun in the oven

  I’ve gone and got myself knocked up. Got myself into trouble, bun in the oven, all the clichés of pregnancy that good Catholic (unmarried) girls...

  From:In your own words

Prevention of mother-to-child transmission news from aidsmap

• Treatment with a ritonavir-boosted protease inhibitor during pregnancy increases risk of preterm delivery

  Antiretroviral therapy during pregnancy is associated with an increased risk of premature delivery, French researchers report in Clinical Infectious Diseases. The large study showed that treatment with a ritonavir-boosted protease inhibitor was especially associated with prematurity. “Our findings suggest a ...

  10 April 2012 | Michael Carter

• Tenofovir use during pregnancy doesn't affect infant size or weight at birth, but may by one year of age

  Use of tenofovir during pregnancy does not have an adverse impact on infant weight or size at birth, according to a large US study published in the online edition of AIDS. The study involved the HIV-negative infants of HIV-positive ...

  03 April 2012 | Michael Carter

• Kenya: Only 4% of pregnant women started ART within 6 months of diagnosis

  Only 4% of HIV-positive pregnant women estimated as needing ART for their own health (CD4 cell counts under 350 cells/mm3) started ART within six months of getting an HIV diagnosis according to a retrospective study of routine hospital data from ...

  30 March 2012 | Carole Leach-Lemens

• Keeping mothers in care: the real-world challenge for PMTCT programmes

  Implementing new recommendations for prevention of mother-to-child transmission (PMTCT) using antiretroviral drugs has resulted in a significant reduction in new infant HIV infections in Zambia, a study of one district, presented at the 19th Conference on Retroviruses and Opportunistic Infections ...

  07 March 2012 | Keith Alcorn

• UK guidelines on treatment of HIV in pregnancy give green light to efavirenz

  New UK draft guidelines on the management of HIV infection in pregnant women recommend that efavirenz-based treatment should no longer be avoided in pregnant women or women who want to have a baby. Pregnant women were previously recommended to avoid efavirenz ...

  17 February 2012 | Keith Alcorn

• Use of some anti-HIV drugs during pregnancy linked to cleft lip and palate; investigators urge cautious interpretation of results

  US investigators have identified a possible association between the use of antiretroviral therapy during pregnancy and an increased risk of having a baby with a cleft lip or palate. The study, published in the January edition of Cleft Palate-Craniofacial Journal, ...

  09 February 2012 | Michael Carter

• Can speeding up nevirapine clearance reduce the risk of resistance after PMTCT use?

  In a bid to reduce the risk of nevirapine resistance after the use of single-dose nevirapine to prevent mother-to-child HIV transmission, several research groups are now experimenting with the use of drugs that can speed up the clearance of nevirapine ...

  20 January 2012 | Carole Leach-Lemens

• Big increase in repeat pregnancy rates in HIV-positive women in UK and Ireland

  Rates of repeat pregnancies among HIV-positive women in the UK and Ireland have increased substantially since 1997, investigators report in the online edition of the Journal of Acquired Immune Deficiency Syndromes. In 2009 over a third of all pregnancies ...

  12 January 2012 | Michael Carter

• Zimbabwe: what will it take to achieve virtual elimination of infant HIV infections?

  Efforts to achieve "virtual elimination" of new HIV infections in infants by 2015 could prove highly challenging, according to computer modelling of the situation in Zimbabwe, one of the most seriously HIV-affected countries in southern Africa.Using a ...

  11 January 2012 | Carole Leach-Lemens

• Nevirapine and cotrimoxazole prophylaxis safe in HIV-exposed, uninfected infants

  Use of nevirapine with cotrimoxazole prophylaxis in HIV-exposed uninfected infants (HIV-EU) until six months of age in Zimbabwe and Uganda was safe with no immediate or long-term adverse effects, researchers on behalf of the HIV Prevention Trials Network (HPTN) 046 protocol ...

  15 December 2011 | Carole Leach-Lemens

More news

Prevention of mother-to-child transmission news selected from other sources

• In HIV Prevention, Protect the Mothers: A Message to the World Health Assembly 2012

  Women with HIV — more than anyone — want to ensure their babies are born free of HIV. However, we are concerned that talking about "saving babies" without putting equal emphasis on upholding women's rights to safety and good health care is a short-term, unsustainable approach to the issue.

  23 May 2012 | RH Reality Check

• Kenya: Doctors who played God

  More than 35 HIV positive women are considering taking action against hospitals and their husbands or family members who participated in their sterilisation. They insist that they were sterilised through coercion, and sometimes without their knowledge, because they were HIV positive.

  21 May 2012 | Daily Nation

• Treat the mother - save the baby

  A new report suggests that paying more attention to their mothers’ health, and focusing on certain damaging but treatable diseases, could be one key to tackling neonatal mortality.

  21 May 2012 | IRIN

• Michel Sidibé: Make Every Day Mother's Day

  There are three simple things we can all do to ensure babies everywhere can be born free from HIV. Together we can go from 390,000 children becoming infected with HIV each year to zero.

  10 May 2012 | Huffington Post

• British HIV Association launches new guidelines for treatment of people living with HIV in the UK

  BHIVA (British HIV Association), the UK's leading association representing professionals in HIV care, has published final versions of guidelines for the treatment of people living with HIV in the UK and specific guidelines for treatment of pregnant women.

  09 May 2012 | British HIV Association

• UNAIDS launches "Believe it. Do it." action campaign to help end new HIV infections among children by 2015

  The Joint United Nations Programme on HIV/AIDS (UNAIDS) today launched a new campaign, "Believe it. Do it.", aimed at bringing attention and action to the global goal of ending new HIV infections among children by 2015 and ensuring mothers living with HIV remain healthy.

  09 May 2012 | UNAIDS

• Flash-heating breastmilk to inactivate HIV is feasible for women in resource-poor countries

  An international team led by UC Davis researchers has found that mothers in sub-Saharan Africa could successfully follow a protocol for flash-heating breastmilk to reduce transmission of human immunodeficiency virus -- the virus that causes AIDS -- to their infants.

  03 May 2012 | Eurekalert Medicine & Health

• Anti-HIV drug use during pregnancy does not affect infant size, birth weight

  Infants born to women who used the anti-HIV drug tenofovir as part of an anti-HIV drug regimen during pregnancy do not weigh less at birth and are not of shorter length than infants born to women who used anti-HIV drug regimens that do not include tenofovir during pregnancy, according to findings from a National Institutes of Health network study.

  02 May 2012 | National Institutes of Health (press release)

• Breastfeeding For Longer Plus Extended ART May Reduce Mother-To-Child HIV Transmission

  Long-term results of the Breastfeeding, Antiretrovirals, and Nutrition (BAN) randomized trial reveals that breastfeeding for a longer period along (6+ months) with antiretroviral therapy (ART) could help reduce mother-to-child HIV transmission as well as improve chances of infant's survival.

  30 April 2012 | HIV / AIDS News From Medical News Today

• Africa: Mothers2mothers - Help for HIV-Positive Women

  HIV/Aids Is Epidemic in Sub - Saharan Africa, but in Kenya, the nongovernmental organization mothers2mothers enables HIV-positive women and their families to live full lives despite the disease.

  28 April 2012 | AllAfrica

More news